A novel STAT inhibitor, OPB-31121, strongly inhibited STAT3 and STAT5 phosphorylation and showed a significant antitumor effect on leukaemia with STAT-addictive oncokinases [126,127]. This evidence concerns the gene SOAT1 and leukemia.